SlowBull
The Business Brief WEDNESDAY, 9 SEPTEMBER 2026
← All stories
Markets

Protagonist Therapeutics authorizes $300 million buyback plan

1 source ·1 article ·17h ago Protagonist Therapeutics

Covered by 1 outlet

Investing 1

All coverage · 1 article

Investing.com News ·17h ago

Protagonist Therapeutics authorizes $300 million buyback plan